Immatics (IMTX) Share-based Compensation (2019 - 2023)

Immatics' (IMTX) quarterly Share-based Compensation came in at $6.0 million in Q2 2023, up 1.17% year-on-year from $5.9 million in Q2 2022, and down 8.37% quarter-over-quarter from $6.6 million in Q1 2023.

Immatics (IMTX) Share-based Compensation (2019 - 2023) Analysis & Trends

Immatics has disclosed Share-based Compensation across 5 years of filings, most recently posting $6.0 million for Q2 2023.

  • Share-based Compensation for Q2 2023 came in at $6.0 million, up 1.17% year-over-year; the trailing twelve-month figure through Jun 2023 was $24.0 million (changed 0.38% YoY), and the FY2022 annual result was $23.0 million, down 23.76% from the prior year.
  • Share-based Compensation came in at $6.0 million for Q2 2023 at Immatics, down from $6.6 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $10.0 million in Q1 2021 to a low of -$182.1 million in Q4 2020.
  • The 5-year median for Share-based Compensation is $5.9 million (2022), against an average of -$17.8 million.
  • Across the five-year window, Share-based Compensation slumped 457119.01% in 2020 and jumped 23165.37% in 2021, its largest moves.
  • Immatics' Share-based Compensation stood at $39848.0 in 2019, then plunged by 457119.01% to -$182.1 million in 2020, then jumped by 102.97% to $5.4 million in 2021, then rose by 10.16% to $6.0 million in 2022, then advanced by 0.65% to $6.0 million in 2023.
  • The last three Share-based Compensation figures came in at $6.0 million (Q2 2023), $6.6 million (Q1 2023), and $6.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Immatics 14.67 Bn 14.67 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 6.00 Mn
Jun 30, 2023 6.00 Mn
Mar 31, 2023 6.55 Mn
Mar 31, 2023 6.55 Mn
Dec 31, 2022 5.96 Mn
Dec 31, 2022 5.96 Mn
Sep 30, 2022 5.51 Mn
Sep 30, 2022 5.51 Mn
Jun 30, 2022 5.93 Mn
Jun 30, 2022 5.93 Mn
Mar 31, 2022 6.40 Mn
Mar 31, 2022 6.40 Mn
Dec 31, 2021 5.41 Mn
Dec 31, 2021 5.41 Mn
Sep 30, 2021 6.37 Mn
Sep 30, 2021 6.37 Mn
Jun 30, 2021 9.59 Mn
Jun 30, 2021 9.59 Mn
Mar 31, 2021 10.02 Mn
Mar 31, 2021 10.02 Mn